Literature DB >> 19732931

Replication cycle of chikungunya: a re-emerging arbovirus.

Maxime Solignat1, Bernard Gay, Stephen Higgs, Laurence Briant, Christian Devaux.   

Abstract

Arboviruses (or arthropod-borne viruses), represent a threat for the new century. The 2005-2006 year unprecedented epidemics of chikungunya virus (CHIKV) in the French Reunion Island in the Indian Ocean, followed by several outbreaks in other parts of the world such as India, have attracted the attention of clinicians, scientists, and state authorities about the risks linked to this re-emerging mosquito-borne virus. CHIKV, which belongs to the Alphaviruses genus, was not previously regarded as a highly pathogenic arbovirus. However, this opinion was challenged by the death of several CHIKV-infected persons in Reunion Island. The epidemic episode began in December 2005 and four months later the seroprevalence survey report indicated that 236,000 persons, more than 30% of Reunion Island population, had been infected with CHIKV, among which 0.4-0.5% of cases were fatal. Since the epidemic peak, the infection case number has continued to increase to almost 40% of the population, with a total of more than 250 fatalities. Although information available on CHIKV is growing quite rapidly, we are still far from understanding the strategies required for the ecologic success of this virus, virus replication, its interactions with its vertebrate hosts and arthropod vectors, and its genetic evolution. In this paper, we summarize the current knowledge of CHIKV genomic organization, cell tropism, and the virus replication cycle, and evaluate the possibility to predict its future evolution. Such understanding may be applied in order to anticipate future epidemics and reduce the incidence by development and application of, for example, vaccination and antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19732931      PMCID: PMC2915564          DOI: 10.1016/j.virol.2009.07.024

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  135 in total

1.  Genetic divergence of Chikungunya viruses in India (1963-2006) with special reference to the 2005-2006 explosive epidemic.

Authors:  Vidya A Arankalle; Shubham Shrivastava; Sarah Cherian; Rashmi S Gunjikar; Atul M Walimbe; Santosh M Jadhav; A B Sudeep; Akhilesh C Mishra
Journal:  J Gen Virol       Date:  2007-07       Impact factor: 3.891

Review 2.  Cellular resistance to induction of interferon.

Authors:  K Paucker; M Boxaca
Journal:  Bacteriol Rev       Date:  1967-06

3.  Comparative immunogenicities of chikungunya vaccines prepared in avian and mammalian tissues.

Authors:  V R Harrison; L N Binn; R Randall
Journal:  Am J Trop Med Hyg       Date:  1967-11       Impact factor: 2.345

4.  Inhibition of endocytosis by anti-clathrin antibodies.

Authors:  S J Doxsey; F M Brodsky; G S Blank; A Helenius
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

5.  Determining divergence times of the major kingdoms of living organisms with a protein clock.

Authors:  R F Doolittle; D F Feng; S Tsang; G Cho; E Little
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

6.  A single mutation in the E2 glycoprotein important for neurovirulence influences binding of sindbis virus to neuroblastoma cells.

Authors:  Peiyu Lee; Ronald Knight; Jolanda M Smit; Jan Wilschut; Diane E Griffin
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Association of the Sindbis virus RNA methyltransferase activity with the nonstructural protein nsP1.

Authors:  S Mi; R Durbin; H V Huang; C M Rice; V Stollar
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

8.  Effect of anti-mu-chain-specific immunosuppression on Chikungunya virus encephalitis of mice.

Authors:  M Giovarelli; I Viano; M Zucca; R Valbonesi; F Dianzani
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

9.  Evolution of alphaviruses in the eastern equine encephalomyelitis complex.

Authors:  S C Weaver; A Hagenbaugh; L A Bellew; L Gousset; V Mallampalli; J J Holland; T W Scott
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

10.  A tyrosine-based motif in the cytoplasmic domain of the alphavirus envelope protein is essential for budding.

Authors:  H Zhao; B Lindqvist; H Garoff; C H von Bonsdorff; P Liljeström
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

View more
  128 in total

1.  The interaction of alphavirus E1 protein with exogenous domain III defines stages in virus-membrane fusion.

Authors:  Gleyder Roman-Sosa; Margaret Kielian
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.

Authors:  Ellen M Bouma; Denise P I van de Pol; Ilson D Sanders; Izabela A Rodenhuis-Zybert; Jolanda M Smit
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  The C-terminal domain of chikungunya virus nsP2 independently governs viral RNA replication, cytopathicity, and inhibition of interferon signaling.

Authors:  Jelke J Fros; Erika van der Maten; Just M Vlak; Gorben P Pijlman
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

Review 4.  Emerging and re-emerging viruses: A global challenge illustrated by Chikungunya virus outbreaks.

Authors:  Christian A Devaux
Journal:  World J Virol       Date:  2012-02-12

5.  Dynamics of Chikungunya Virus Cell Entry Unraveled by Single-Virus Tracking in Living Cells.

Authors:  Tabitha E Hoornweg; Mareike K S van Duijl-Richter; Nilda V Ayala Nuñez; Irina C Albulescu; Martijn J van Hemert; Jolanda M Smit
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

6.  The synergistic effect of nsP2-L618, nsP3-R117, and E2-K187 on the large plaque phenotype of chikungunya virus.

Authors:  Benjawan Thoka; Thitigun Jaimipak; Supachoke Onnome; Sutee Yoksan; Sukathida Ubol; Rojjanaporn Pulmanausahakul
Journal:  Virus Genes       Date:  2017-11-28       Impact factor: 2.332

7.  BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1).

Authors:  Philip H Jones; Martina Maric; Marisa N Madison; Wendy Maury; Richard J Roller; Chioma M Okeoma
Journal:  Virology       Date:  2013-02-12       Impact factor: 3.616

8.  Neutralizing Antibodies Inhibit Chikungunya Virus Budding at the Plasma Membrane.

Authors:  Jing Jin; Jesús G Galaz-Montoya; Michael B Sherman; Stella Y Sun; Cynthia S Goldsmith; Eileen T O'Toole; Larry Ackerman; Lars-Anders Carlson; Scott C Weaver; Wah Chiu; Graham Simmons
Journal:  Cell Host Microbe       Date:  2018-08-23       Impact factor: 21.023

9.  Association of ABO blood groups with Chikungunya virus.

Authors:  Naresh C V M Kumar; Mahathi Nadimpalli; Vishnu R Vardhan; Sai D V R Gopal
Journal:  Virol J       Date:  2010-06-25       Impact factor: 4.099

10.  A chimeric vesiculo/alphavirus is an effective alphavirus vaccine.

Authors:  Anasuya Chattopadhyay; Eryu Wang; Robert Seymour; Scott C Weaver; John K Rose
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.